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Background: Klebsiella pneumoniae has emerged worldwide as a cause of pyogenic liver abscess (PLA) often
complicated by meningitis and endophthalmitis. Early detection of this infectious disease will improve its clinical
outcome. Therefore, we tried to isolate immunodominant proteins secreted by K. pneumoniae strains causing PLA.
Results: The secreted proteins of the NTUH-K2044 strain were separated by two-dimensional electrophoresis and
then immunoblotted using convalescent sera from patients with K. pneumoniae PLA. A ~30-kDa immunodominant
protein was then identified. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed an open
reading frame (KP1_p307) located on the pK2044 plasmid and bioinformatic analysis identified this protein as a
signal peptide of unknown function. The KP1_p307 gene was more prevalent in PLA strains and capsular type
K1/K2 strains, but disruption of this gene in NTUH-K2044 strain did not decrease virulence in mice. Ten of fourteen
(71%) sera from patients with K. pneumoniae PLA were immunoreactive with the recombinant KP1_p307 protein.
Seroconversion demonstrated by a rise in serum titer in serial serum samples confirmed that antibodies against the
KP1_p307 protein were elicited after infection.
Conclusions: The KP1_p307 protein could be used as an antigen for early serodiagnosis of K. pneumoniae PLA,
particularly in K1/K2 PLA strains.
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Klebsiella pneumoniae is a common Gram-negative
enteric bacterium that causes hospital-acquired urinary
tract infection, septicemia, and pneumonia as well as
community-acquired pneumonia. Recently, community-
acquired pyogenic liver abscess (PLA) caused by K.
pneumoniae complicated with metastatic meningitis
and endophthalmitis has emerged globally especially in
Asia [1-13]. Based on analysis of data from the National
Health Insurance Database in Taiwan, cases of PLA per
year have increased from 1,950 in 1997 to 3,083 in 2008* Correspondence: wangjt@ntu.edu.tw
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unless otherwise stated.[14,15]. Among the 506 case-patients with PLA admitted
to National Taiwan University Hospital (NTUH) from
2000 through 2004, 358 case-patients had positive culture
results, and 286 (79.9%) of these 358 case-patients had
positive culture results showing K. pneumoniae infection
[15]. In a nationwide prospective study of PLA in Korea,
K. pneumoniae was the most common etiologic organism
(78.2%) [2]. K. pneumoniae was also reported as the most
common etiological organism of PLA in New York, Hong
Kong, Singapore, and Australia [2-11]. The mortality rates
were 10% among those with K. pneumoniae-caused PLA
and 30 ? 40% among those with metastatic meningitis.
The survivors of meningitis usually had severe neuro-
logical sequelae and K. pneumoniae endophthalmitis
usually resulting in blindness of the affected eyes.is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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metastatic infection and mortality among patients with
K. pneumoniae liver abscess [16]. Most of the severe
complications occurred within the first 3 days after
hospital admission. Percutaneous drainage of primary
liver abscess caused by K. pneumoniae lowered rates of
mortality, metastatic infection, and complications. A
previous study also observed that timing of appropriate
antimicrobial therapy is a major determinant of sur-
vival and neurological outcome for patients with K.
pneumoniae meningitis [17]. Therefore, rapid diagno-
sis and proper treatment for this invasive disease are
required.
When a bacterial infection is suspected because of
symptoms (such as fever) and increased white blood cell
counts, the standard procedure in hospitals is to isolate
and identify the bacterium. Identification of K. pneu-
moniae using automated or manual biochemical tests
requires at least 24 to 48 hours. However, identification
through molecular or immunologic techniques of bac-
terial nucleic acid and antigen detection can accelerate
the diagnosis of bacterial infectious diseases. A real-
time PCR assay with specific primers and hybridization
probes targeting 16S rRNA gene was developed for the
direct detection of K. pneumoniae from positive blood
culture bottles [18]. But this method still requires cul-
ture enrichment.
In this study, we used a proteomic strategy to identify
an immunodominant protein in K. pneumoniae strains
causing PLA and evaluated the sensitivity and specificity
of an immunoblot method for detecting antibodies to
this antigen in patient sera.Methods
Ethics statement
All the clinical bacterial strains used in this study were
provided by the strain collection of National Taiwan
University Hospital (NTUH) in Taiwan. The Ethics
Committee approved that no formal ethical approval
was needed to use these clinically obtained materials,
because the strains were remnant from patient sam-
ples, and the data were analyzed anonymously. The
collection and study of serum samples in this study
was approved by the Institutional Review Board of
NTUH and written informed consent was obtained
from each participant (approval number: 200904046R).
All animal experiments followed the guidelines in the
Handbook of Laboratory Animal Care of the National
Laboratory Animal Breeding and Research Center, Na-
tional Science Council of Taiwan, and were approved
by the Institutional Animal Care and Use Committee
of the National Taiwan University College of Medicine
(approval number: 20130005).Bacterial strains and culture conditions
The 74 K. pneumoniae clinical isolates used in this study
were collected from NTUH from 1997 to 2003 [19].
Forty-two were PLA strains isolated from the blood of
patients with PLA with or without meningitis or en-
dophthalmitis complications, and 32 were non-tissue-
invasive strains isolated from patients with sepsis but
not PLA or other metastatic infections in any tissue.
K. pneumoniae and Escherichia coli were cultured in
LB medium at 37?C supplemented with appropriate
antibiotics, including 50 μg/ml kanamycin and 100 μg/ml
ampicillin.
Serum samples
The serum samples from fourteen patients with K. pneu-
moniae PLA and three patients with non-K. pneumoniae
liver abscess were obtained from NTUH in 2008 ~ 2010.
The dates of admission and sera collection were re-
corded. The diagnosis of liver abscess was confirmed by
abdominal sonography or computed tomography, as well
as isolation and identification of the pathogens from
blood or abscess aspiration. The serum samples from
twelve patients with K. pneumoniae infections (other
than PLA) were obtained from Taipei Veterans General
Hospital (VGH) in 2012. The diagnosis was based on
clinical presentations and history.
Purification of secreted proteins
NTUH-K2044 strain was cultured overnight and pel-
leted by centrifugation. The culture supernatant was
collected and 0.45-μm filtered. The secreted proteins
were precipitated by adding trichloroacetic acid to a
final 20% concentration and incubating on ice for 30
minutes, collected after centrifugation, washed several
times with cold acetone, air-dried, dissolved in 1.5 M
Tris-Cl (pH 8.8), and assayed to determine protein con-
centration using the Bradford method.
Two-dimensional gel electrophoresis and immunoblotting
The proteins (2? 3 mg) were separated by two-dimensional
electrophoresis. Briefly, protein extract in sample buffer
(8 M urea, 2% Pharmalyte pH 3 ? 10, 60 mM DTT, 4%
CHAPS, bromophenol blue) was first separated on IPG
strips (Immobiline DryStrip pH 3 ? 10), then on 12%
sodium dodecyl sulfate (SDS)-polyacrylamide gels (PAGE;
18 cm ? 20 cm), and the separated proteins were trans-
ferred onto a poly(vinylidene) fluoride (PVDF) mem-
brane (Millipore, Bedford, MA). The membrane was
incubated with blocking buffer (5% skimmed milk in
PBS with 0.5% Tween 20) for 1 h at room temperature,
primary antibody (sera from patients or healthy subjects
or anti-GST antibody or anti-KP1_p307 antibody diluted
in blocking buffer), secondary antibody (horseradish
peroxidase [HRP]-conjugated goat anti-human IgG or
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mecula, CA]), and then enhanced chemiluminescence
(ECL) reagent.
Liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis
The protein spots on the Coomassie blue stained two-
dimensional gel were excised and digested by trypsin.
The peptide mixture was analyzed using a nanoAcquity
system (Waters, Milford, MA) connected to an LTQ-
Orbitrap Elite hybrid mass spectrometer (Thermo Fisher
Scientific, Bremen, Germany) equipped with a nanospray
interface (Proxeon, Odense, Denmark).
Expression and purification of recombinant KP1_p307
protein
KP1_p307 gene was amplified by PCR using primers
KPP307-074F (5′-CCGTCGCCGGCGATAAATC-3′) and
KPP307-916R (5′-CGTAGATATCAGCGTTACCAAAG-
3′) and then cloned into a pGEM-T easy plasmid. The
KP1_p307 was sub-cloned into the Klenow fragment
blunting-EcoRI site of a pGEX-4T-1 plasmid. The resulting
plasmid was transformed into E. coli DH10B. KP1_p307
gene was amplified by PCR using primers KPP307-076F
(5′-GTCGCCGGCGATAAATCCGG-3′) and KPP307R
(5′-TTATTCGTAGATATCAGCGTTACC-3′) and cloned
into the blunt-end SmaI site of a pQE32 plasmid. The
resulting plasmid was transformed into E. coli M15/
pREP4. The recombinant GST-fused KP1_p307 protein
and His-tagged KP1_p307 protein were expressed under
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG)
induction at 37?C and purified per the manufacturer ? s
instructions. The immuno-reactivities to GST-fused
KP1_p307 protein and His-tagged KP1_p307 protein
were not different. However, the yield of purified His-
tagged KP1_p307 protein was higher than that of puri-
fied GST-fused KP1_p307 protein because His-tagged
protein (either in supernatant or in inclusion body)
could be purified under denaturing condition. There-
fore, we used the His-tagged KP1_p307 protein for
further examination of the diagnostic application of
KP1_p307 protein.
Knockout of KP1_p307
The KP1_p307 gene and its flanking regions were amplified
by PCR using primers 307KO-F (5′-GTCCTGCTGAA
ACATGACC-3′) and 307KO-R (5′-ACACTATCGTGT
CACAGATG-3′). Nucleotides 64 ? 902 of the KP1_p307
coding sequence were replaced by a kanamycin resistant
gene. The deletion fragment was then cloned into the
suicide vector pUT containing a spectinomycin resist-
ant gene as a selective marker to distinguish between
single and double crossovers for chromosomal integra-
tion [20,21]. The resulting plasmid was transferred toNTUH-K2044 by conjugation. Chromosomal deletion
of the KP1_p307 mutant was confirmed by PCR with
different primer pairs.
Virulence assay in mice
Female 5-week-old BALB/cByl mice were inoculated
with K. pneumoniae intraperitoneally as previously
described [22]. Four mice were used to test the effects
of each inoculum. After inoculation, the mice were
observed for 30 days. The LD50 was calculated using
the method established by Reed and Muench. For
in vivo competition, the KP1_p307 mutant strain and
the fully virulent placZ deletion mutant strain in the
logarithmic phase were mixed at a 1:1 ratio (1 ? 10 3
colony-forming units each) in saline, and inoculated
intraperitoneally into eight 5-week-old BALB/c mice as
previously described [23]. The amounts of bacteria in
livers and spleens one day after inoculation were deter-
mined by plating serial dilutions onto LB agar containing
1 mmol/L IPTG and 50 mg/mL X-gal. In vivo competition
was assessed using the competitive index (the output to
input ratio of the KP1_p307 mutant strain [blue colony]
to the placZ deletion mutant strain [white colony]).
Immunoblotting of recombinant KP1_p307 protein with
patient sera
The purified recombinant His-tag KP1_p307 protein was
separated on 12% SDS-PAGE (~5 ng per lane) and then
transferred onto a membrane. Patients? sera (1:2000 dilu-
tion) were screened simultaneously using Mini-PROTEAN
II Multiscreen Apparatus (Bio-Rad, Hercules, CA). Those
collected first were screened first, and immunoblotting
with serial sera was performed when the first collected
serum was antibody negative.
Capsular typing by wzc sequencing
Capsular types of the K. pneumoniae strains were deter-
mined by wzc genotyping [24]. The sequences of CD1-
VR2-CD2 region were compared with those of reference
strains by NCBI-nucleotide blast and the corresponding
capsular types were determined.
Results
Identification of immunodominant proteins in
NTUH-K2044 strain
Proteins released by bacteria to the extracellular environ-
ment are usually the antigens that elicit immune re-
sponses, have diagnostic value, and can provide protective
immunity. To identify immunodominant proteins in
K. pneumoniae NTUH-K2044 strain causing pyogenic
liver abscess (PLA), the secreted proteins were isolated
as described above and analyzed by immunoblotting
using sera from one healthy subject and two patients in
the convalescent phase of PLA caused by K. pneumoniae
Figure 1 Identification of immuno-dominant proteins in
NTUH-K2044 by one dimensional-PAGE. Lane 1, the coomassie
blue staining of the secreted proteins of NTUH-K2044 strain. Lane 2,
the immunoblotting with serum from healthy subject. Lane 3, the
immunoblotting with serum from patient 1 with K. pneumoniae
causing PLA. Lane 4, the immunoblotting with serum from patient
2 with K. pneumoniae causing PLA. The arrow heads indicate the
putative protein immuno-reactive to sera from patients with PLA.
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K. pneumoniae PLA were primarily used to identify
immunodominant proteins secreted by K. pneumoniae
strains causing PLA. Because sera obtained from pa-
tients in the convalescent stage were considered to beFigure 2 Identification of immuno-dominant proteins in NTUH-K2044
with serum from healthy subject. B, the immunoblotting with serum from
staining of the secreted proteins of NTUH-K2044 strain. The arrow heads in
with PLA.especially rich in antibodies against the infectious
agent. A 30-kDa band was recognized by the sera from
the two patients but not the serum from the healthy
subject. Further separation by two-dimensional gel
electrophoresis and immunoblotting with the above
sera followed by Coomassie blue staining (Figure 2)
identified a similar band (approximately 30-kDa mo-
lecular weight and isoelectric point [pI] ranging from 7
to 9) that was immunoreactive with patients ? sera and
therefore a possible candidate protein for immuno-
logical diagnosis of PLA caused by K. pneumoniae.
Identification of the protein immunoreactive to sera from
patients with PLA
The protein spots on the two-dimensional gels were ex-
cised, digested by trypsin, and analyzed by LC-MS/MS.
The obtained peptide sequences were compared with
the whole genome sequences of NTUH-K2044 strain
(chromosome and a large plasmid: AP006725.1 and
AP006726.1). A 921-bp open reading frame (KP1_p307)
located on the large plasmid pK2044 was confirmed.
The sequences of peptides obtained from LC-MS/MS
represented 93.1% of KP1_p307 protein sequences. The
theoretical pI and molecular weight of KP1_p307 pro-
tein (i.e., 8.87 and 32,254.72-Da) matched those of the
immunoreactive protein. The amino acid sequences of
KP1_p307 revealed 47% (107/229) identity to a hypothet-
ical protein of Lactobacillus rossiae (WP_026017099.1)
and 53% (95/180) identity to a hypothetical protein of
Enterococcus dispar (WP_016173221.1). Bioinformaticby two dimensional-gel electrophoresis. A, the immunoblotting
patient 2 with K. pneumoniae causing PLA. C, the coomassie blue
dicate the putative protein immuno-reactive to sera from patients
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peptide located at N-terminal residues 1 to 24 but had
no known function.
Confirmation of the immunoreactivity of KP1_p307
protein
The recombinant GST-KP1_p307 protein was expressed
and purified in E. coli to confirm its immunoreactivity.
Sera from another four patients with PLA and three
healthy subjects were used to immunoblot the recom-
binant GST-KP1_p307 protein. The GST-KP1_p307 pro-
tein was immunoreactive with sera from patients but
not from healthy subjects (Figure 3). The immunoreac-
tive signal of the secreted proteins disappeared when the
immunoreactive serum was pre-incubated with the re-
combinant GST-KP1_p307 protein but not with GST
protein (data not shown). These results confirmed that
KP1_p307 protein was the candidate protein identified
above.
Prevalence of strains with KP1_p307
The prevalence of PLA strains and non-tissue invasive
strains with KP1_p307 was determined by PCR and
Western blotting using rabbit anti-KP1_p307 serum
(Table 1). The results of PCR and Western blottingFigure 3 Confirmation of the immune-reactivity of the
recombinant KP1_p307 protein. The recombinant GST-KP1_p307
protein was separated on SDS-PAGE and immunoblotted with sera from
another four patients (lane 1-4 of panel A) or from healthy subjects (lane
2-4 of panel B) or anti-GST antibody (lane 1 of panel B).were consistent. The prevalence of PLA strains with
KP1_p307 (39 out of 42) was significantly higher than
that of non-tissue invasive strains with KP1_p307 (6
out of 32) (Chi-square analysis, P < 0.0001). K1 and K2
were the most prevalent capsular types causing PLA
and were strongly associated with virulence. Thirty-
seven of the 42 PLA strains were K1/K2, whereas 4 of
the 32 non ? tissue-invasive strains were found to be K1/
K2. The prevalence of K1/K2 strains with KP1_p307 (39
out of 41) was significantly higher than that of non-K1/
K2 strains with KP1_p307 (6 out of 33) (Chi-square ana-
lysis, P < 0.0001). Because this gene might be associated
with bacterial virulence, a KP1_p307 knockout mutant
of the NTUH-K2044 strain was generated and its viru-
lence was tested in mice. The survival of mice intra-
peritoneally infected with 1 ? 10 3 cfu of wild type or
KP1_p307 knockout mutant was not significantly
different (Figure 4A). Knockout of KP1_p307 did not
increase the lethal dose (LD50 < 1 ? 10 3 cfu) of NTUH-
K2044 strain given intraperitoneally. Moreover, the in vivo
competition between the wildtype and KP1_p307 knock-
out mutant strains was also not significantly affected
(Figure 4B).
Diagnostic application of KP1_p307 protein in K.
pneumoniae PLA
Sera from 14 patients with K. pneumoniae PLA were col-
lected to evaluate the diagnostic application of KP1_p307
protein (Table 2). Ten of the 14 (71.4%) sera were immu-
noreactive with the recombinant KP1_p307 protein. Be-
cause not all the PLA strains have KP1_p307, the
isolates from the four patients whose sera did not react
to the recombinant KP1_p307 protein were tested to
determine whether they possess KP1_p307. Two out of
these four strains did not have KP1_p307, and therefore
could not elicit these antibodies. Moreover, sera from
three patients with LA not caused by K. pneumoniae
and sera from ten healthy subjects were not immu-
noreactive with the recombinant KP1_p307 protein.
Therefore, presence of antibodies against the KP1_p307
protein can be implicated in K. pneumoniae PLA.
Antibodies against the KP1_p307 could be detected
in the first serum sample (collected 1 ? 26 days after
admission) from eight of the ten patients with positive
reactions. Four of these eight patients had positive
serological reactions to KP1_p307 protein on the first
day after hospital admission (Table 2). The other two
patients (I and J) were observed to seroconvert (Figure 5)
on the 5th and 10th day after admission, respectively,
and to still have anti-KP1_p307 antibody 4 months after
infection (on the 110th day). These results confirm that
the antibodies against the KP1_p307 protein were elic-
ited after infections. Therefore, the KP1_p307 protein
could be used to serodiagnose K. pneumoniae PLA.
Table 1 The prevalence of KP1_p307 among 42 PLA strains and 32 non-tissue invasive strains
PLA strains (n = 42) Non-tissue invasive strains (n = 32)
K1/K2 non-K1/K2 K1/K2 non-K1/K2
KP1_p307 + 35 4 4 2
KP1_p307 − 2 1 0 26
The prevalence of KP1_p307: PLA strains vs. non-tissue invasive strains (P < 0.0001, Chi-square analysis); K1/K2 strains vs. non-K1/K2 strains (P < 0.0001,
Chi-square analysis).
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pneumoniae infections other than PLA
The diagnostic application of KP1_p307 protein in K.
pneumoniae infections other than PLA was further ex-
amined (Table 3). Sera from 12 non-PLA patients were
obtained from VGH and their K. pneumoniae isolates
were also collected. The capsular type was determined
by wzc genotyping and the presence of KP1_p307 was
determined by PCR. The three strains with K1 or K2
capsular type all possess KP1_p307 and five out of the 9
non-K1/K2 strains (55.6%) have KP1_p307. Four of the 8
sera (50%) collected from patients infected with
KP1_p307-positive K. pneumoniae strains when they vis-
ited the hospital were immunoreactive with the recom-
binant KP1_p307 protein.
Discussion
In this study, we identified an immunodominant antigen
in a K. pneumoniae PLA strain by a proteomic approach
and evaluated its application to the serodiagnosis of K.
pneumoniae PLA. The sensitivity of K. pneumoniae PLAFigure 4 The virulence of KP1_p307 knockout mutant. A, The survival
knockout mutant. Female 5-week-old BALB/cByl mice were inoculated with
intraperitoneally (four mice each group). The survival of mice infected with
(P = 0.870, log-rank test). B, The in vivo competition between wild type and
strain (blue colony on LB agar containing IPTG and X-gal) and the placZ de
and the placZ deletion mutant strain (white colony) were mixed at a 1:1 ra
amounts of bacteria in livers and spleens in the next day after inoculation
The CI of lacZ mutant/WT in liver is 1.009 ? 0.101 and that of KP1_p307 mut
spleen is 1.016 ? 0.073 and that of KP1_p307 mutant/ lacZ mutant in spleen
mutant was not significantly different (P = 0.315 in liver, P = 0.808 in spleendetection was 71.4% (10/14) and four out of six sera
(66.7%) collected on the first day of hospitalization for
K. pneumoniae PLA were positive for anti-KP1_p307
antibodies. Our previous study indicated that 80% of pa-
tients with PLA were caused by K. pneumoniae infection
[15]. Therefore, the case of non-K. pneumoniae PLA was
relatively few. We included serum samples from three
patients with LA not caused by K. pneumoniae and sera
from ten healthy subjects to confirm the specificity. The
results indicated that the specificity was 100% (13/13).
The detection of antibodies against KP1_p307 protein
could be performed directly using sera and did not re-
quire the cultivation of bacteria. Although the sensitivity
and specificity of this test still need to be confirmed by
using a larger number of clinical samples, we suggest
that detection of anti-KP1_p307 antibody was consid-
ered to be an easy and rapid method for early screening
of K. pneumoniae PLA. As shown in Figure 5, patient I
was observed to still have anti-KP1_p307 antibody 4
months after infection (on the 110th day), therefore anti-
body titers could persisted for months after successfulcurve of mice with intraperitoneal infection of wild type or KP1_p307
1 ? 10 3 cfu of K. pneumoniae wild type or KP1_p307 knockout mutant
wild type or KP1_p307 knockout mutant was not significantly different
KP1_p307 mutant in liver and spleen of BALB/c mice. The wild type
letion mutant (white colony) or KP1_p307 mutant strain (blue colony)
tio and inoculated intraperitoneally into eight BALB/c mice. The
were determined. The in vivo competition index (CI) was calculated.
ant/lacZ mutant in liver is 0.865 ? 0.094. The CI of lacZ mutant/WT in
is 0.981 ? 0.121. The in vivo competition of wild type and KP1_p307
, Student? s t test).
Table 2 The immuno-reaction to KP1_p307 protein of sera from 17 patients with liver abscess
Patients Diagnosis Serum collection day (the day after admission) KP1_p307 PCR








I 3 5 7 110 ND
J 2 4 10 14 25 39 ND
K 2 26 +
L 1 7 22 +
M 3 7 55 −
N 1 6 14 −
O PLA (non-Kp) 5 30 60
P PLA (non-Kp) 1 11
Q amoebic LA 1 13
The number in boldface indicates the positive reaction to KP1_p307 protein and the number in standard indicates the negative reaction to KP1_p307 protein.
ND: not determined.
Figure 5 The seroconversion to KP1_p307 in two patients with
K. pneumoniae causing PLA. The recombinant His-tag KP1_p307
protein was separated on SDS-PAGE and immunoblotted with serial
sera collected from two patients with K. pneumoniae causing PLA
simultaneously by using Bio-Rad Mini-PROTEAN II Multiscreen Apparatus
(in panels A and B, respectively). The numbers under the panel indicate
the date after admission to hospital. The seroconversion was observed
in panel A (the 5th day) and in panel B (the 10th day).
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gen could not be used in the diagnosis of K. pneumoniae
re-infection. However, because we did not have adequate
follow-up sera, how long the anti-KP1_p370 antibodies
persisted could not be determined.
The KP1_p307 protein was predicted to have a signal
peptide similar to that of the KP1_p307 protein present
in the fraction secreted from bacteria. The amino acid
sequences of KP1_p307 revealed approximately 50%
identity to a hypothetical protein of L. rossiae and a
hypothetical protein of E. dispar. Hence, the cross-
reactivity of antibodies against L. rossiae and E. dispar
to KP1_p307 protein may occur. However, the infec-
tions caused by L. rossiae and E. dispar were extremely
rare. There were neither L. rossiae nor E. dispar isolates
in the bacteria collection of NTUH, Taipei VGH and
Chang Gung Memorial Hospital, thus we have difficul-
ties to examine the crossreactivity. But, we expected
that the possible crossreactivity would not interfere in
the application of KP1_p307 to the serodiagnosis of
K. pneumoniae PLA. Moreover, the function of KP1_p307
protein remains unknown and difficult to study. Although
the presence of this protein was correlated with K. pneu-
moniae PLA, knock out of KP1_p307 did not decrease
the virulence of K. pneumoniae NTUH-K2044 strain in
mice even its in vivo ability to compete with wild type
strain. Our preliminary result demonstrated that the
anti-KP1_p307 antibodies could not block the infection
of K. pneumoniae NTUH-K2044 strain in mice (data
Table 3 The immuno-reaction to KP1_p307 protein of sera from the 12 patients with K. pneumoniae infections
(other than PLA)
Patients Diagnosis Capsular type1 KP1_p307 PCR KP1_p307 immunoreaction
1 primary bacteremia K2 + +
2 necrotizing fasciitis with bacteremia K2 + −
3 primary bacteremia K1 + −
4 necrotizing fasciitis K62 + +
5 primary bacteremia K58 + −
6 renal abscess with bacteremia K5 + +
7 primary bacteremia K74 − −
8 cholecystitis with bacteremia K58 − −
9 cholecystitis with bacteremia K46 − −
10 urinary tract infection K58 + +
11 pneumonia with bacteremia K68 + −
12 primary bacteremia K28 − −
1Capsular types of these strains were determined by using wzc genotyping.
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KP1_p307 protein and anti-KP1_p307 antibody is still
needed.
Previous studies have demonstrated the correlation of
the virulence o f K. pneumoniae K1 strains with the
presence of aerobactin [25,26]. Our previous study also
reported that p-rmpA gene (for regulator of mucoid
phenotype A) was associated with K. pneumoniae PLA
[27]. However, knockout of the iuc region (which en-
codes aerobactin) or p-rmpA did not decrease its viru-
lence in mice [27,28]. Here, the KP1_p307 was also
associated with K. pneumoniae PLA, but knockout of
this gene had no influence on virulence. Because these
genes (iuc region, p-rmpA and KP1_p307) are all located
on the large plasmid and associated with bacterial viru-
lence, we propose that other virulence factors might be
present in the large plasmid of K. pneumoniae. These
genes could serve as markers of bacterial virulence due
to their co-inheritance together with virulence genes car-
ried by this plasmid.
As shown in Table 1, the presence of KP1_p307 was
also correlated with capsular type K1/K2. The K. pneu-
moniae strains with capsular types K1 and K2 are more
virulent than those with other capsular types [25,29].
Therefore, the KP1_p307 can be used to detect not only
K. pneumoniae PLA but also possibly other infections
caused by capsular type K1/K2 strains. The majority of
K. pneumoniae PLA strains were capsular type K1 and
K2 [19]. But we did not obtain all the K. pneumoniae
strains isolated from these 14 PLA patients in this study
(Table 2); consequently the capsular types of these iso-
lates were unknown. Besides PLA, the diagnostic appli-
cation of KP1_p307 protein in K. pneumoniae other
infections was also examined. All strains with K1 or K2
capsular type possess KP1_p307 gene and 55.6% of non-K1/K2 strains also have KP1_p307. But only 50% of sera
collected from patients infected with KP1_p307-positive
K. pneumoniae strains were immunoreactive with
KP1_p307 protein. Because these sera samples were col-
lected at the first day when the patients visited the hos-
pital, the anti- KP1_p307 antibodies may not yet be
elicited at this very early time point. These results dem-
onstrated that the detection of anti-KP1_p307 antibody
implicated the infections by several capsular types (par-
ticularly K1 and K2) of K. pneumoniae which carry a
virulent plasmid.
There are several immunogenic antigens of K. pneu-
moniae, such as OmpA and OmpK36 etc., have been
reported previously [30]. The immuno-reactivity to
OmpK36 of sera obtained from PLA patients was also
examined. But the sera samples from all the K. pneumo-
niae PLA patients were not immuno-reactive to the
recombinant OmpK36 protein (data not shown). We
speculated that OmpK36 antigen located on the outer
membrane might be masked by capsule and might not
be exposed, because the strains causing PLA were ob-
served to be heavily encapsulated [22]. The antibodies
against OmpK36 might be produced at a later stage or
might not be elicited during K. pneumoniae PLA infec-
tions. Moreover, OmpK36 protein is commonly distrib-
uted among K. pneumoniae strains and has sequence
similarity to that of E. coli. These results indicated that
KP1_p307 would be a better antigen than OmpK36 to
serodiagnose K. pneumoniae PLA.
Conclusions
In conclusion, an immunodominant antigen, KP1_p307,
was identified in a K. pneumoniae strain causing PLA.
The KP1_p307 gene was located on the large plasmid
and more prevalent in PLA strains and capsular type
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http://www.biomedcentral.com/1471-2180/14/321K1/K2 strains, but deletion of KP1_p307 did not de-
crease the virulence of this strain in mice. The high
sensitivity and specificity demonstrated here indicates
that the Kp1_p307 protein could be used to serodiag-
nose K. pneumoniae PLA or other infections.
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